The Multiple Myeloma Research Foundation (MMRF) has announced a series of Walk/Run events scheduled to take place across the United States from August to December. These events represent a significant opportunity for community engagement and fundraising for multiple myeloma research, the second most common blood cancer. For over 25 years, the MMRF has been at the forefront of multiple myeloma research, raising more than $600 million and contributing to the development of over 15 FDA-approved therapies. These efforts have played a crucial role in tripling the life expectancy of myeloma patients since the foundation's inception.
Michael Andreini, President and Chief Executive Officer of the MMRF, emphasized the progress made in myeloma research while acknowledging the work that remains. Looking back to where we began over 25 years ago, myeloma research has been transformed thanks to the persistence of the entire myeloma community. Yet, there is still much work to be done, Andreini stated. He reaffirmed the foundation's commitment to driving innovation through collaboration and taking calculated risks to benefit myeloma patients worldwide. The upcoming Walk/Run events are part of this broader initiative to raise funds and awareness.
The impact of these events extends beyond immediate fundraising. The MMRF plans to use the funds raised to accelerate the development and delivery of novel therapies, utilize data to drive optimal and more personalized treatment approaches, and empower myeloma patients with information and resources to advocate for their care and extend their lives. Participants can register for free and begin fundraising immediately through the foundation's website at https://www.themmrf.org. Most events are scheduled for weekends, typically starting between 8:15 am and 9:00 am and concluding between 10:30 am and 11:00 am.
Two inaugural events are set to kick off the series in California this August. The first will take place on Saturday, August 17th, at Griffith Park in Los Angeles, chaired by Dr. Scott Goldsmith from City of Hope. The second event is scheduled for Saturday, August 24th, at Marina Green in San Francisco, chaired by Dr. Jeffrey Wolf, Dr. Tom Martin, and Dr. Ajai Chari from UCSF. A unique feature of these events is the presentation of the Spirit of Hope Award. This recognition is given to individuals or groups who demonstrate extraordinary commitment to the MMRF and inspire hope through their resilience, perseverance, and dedication to the foundation's mission.
The MMRF's achievements to date are substantial. The foundation has invested over $600 million in research, facilitated the opening of nearly 100 clinical trials, and helped bring more than 15 FDA-approved drugs to market. These efforts have contributed significantly to tripling patient survival rates. As the largest nonprofit organization solely focused on accelerating a cure for multiple myeloma, the MMRF's work extends beyond research funding. The foundation is committed to advancing health equity to ensure all myeloma patients can benefit from scientific and clinical advances. This comprehensive approach includes driving the development of next-generation therapies, leveraging data for personalized treatment approaches, and empowering patients with information and resources.
With events planned across the country, the MMRF aims to engage communities nationwide in their mission to accelerate a cure for multiple myeloma and improve the lives of patients and their families. The foundation's track record demonstrates how sustained investment in research can transform outcomes for patients facing serious diseases. The Walk/Run events serve as both fundraising vehicles and community-building opportunities that bring together patients, families, researchers, and supporters around a common goal of advancing treatment options and ultimately finding a cure for multiple myeloma.
